These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 23222168)

  • 1. Thrombelastographic characterization of coagulation/fibrinolysis in horses: role of carboxyheme and metheme states.
    Olver CS; Nielsen VG
    Blood Coagul Fibrinolysis; 2013 Apr; 24(3):273-8. PubMed ID: 23222168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbon monoxide and nitric oxide modulate α₂-antiplasmin and plasmin activity: role of heme.
    Arkebauer MR; Kanaparthy SS; Malayaman SN; Vosseller K; Nielsen VG
    Blood Coagul Fibrinolysis; 2011 Dec; 22(8):712-9. PubMed ID: 22024794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tobacco smoke-induced hypercoagulation in human plasma: role of carbon monoxide.
    Nielsen VG; Hafner DT; Steinbrenner EB
    Blood Coagul Fibrinolysis; 2013 Jun; 24(4):405-10. PubMed ID: 23429254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redox-based thrombelastographic method to detect carboxyhemefibrinogen-mediated hypercoagulability.
    Nielsen VG; Arkebauer MR; Vosseller K
    Blood Coagul Fibrinolysis; 2011 Dec; 22(8):657-61. PubMed ID: 21822126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbon monoxide releasing molecule-2 enhances coagulation and diminishes fibrinolytic vulnerability in subjects exposed to warfarin.
    Nielsen VG; Khan ES; Kirklin JK; George JF
    Thromb Res; 2010 Jul; 126(1):68-73. PubMed ID: 20406708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbon monoxide releasing molecule-2 enhances coagulation and attenuates fibrinolysis by two mechanisms: insights gained with colloid dilution.
    Cohen JB; Persaud JM; Malayaman SN; Nielsen VG
    Blood Coagul Fibrinolysis; 2011 Jan; 22(1):60-6. PubMed ID: 21157300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbon monoxide releasing molecule-2 enhances α2-antiplasmin activity.
    Malayaman SN; Cohen JB; Machovec KA; Bernhardt BE; Arkebauer MR; Nielsen VG
    Blood Coagul Fibrinolysis; 2011 Jun; 22(4):345-8. PubMed ID: 21330914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbon monoxide-releasing molecule-2 decreases fibrinolysis in human plasma.
    Nielsen VG; Kirklin JK; George JF
    Blood Coagul Fibrinolysis; 2009 Sep; 20(6):448-55. PubMed ID: 19581800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbon monoxide releasing molecule-2 attenuates the anticoagulant and amplifies the hypofibrinolytic effects of hypothermia in human plasma in vitro.
    Nielsen VG; George SJ
    Blood Coagul Fibrinolysis; 2011 Jan; 22(1):67-72. PubMed ID: 21157299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Freezing does not decrease carbon monoxide-mediated hypercoagulation and hypofibrinolysis in human plasma.
    Nielsen VG; Hafner DT
    Blood Coagul Fibrinolysis; 2012 Dec; 23(8):784-6. PubMed ID: 22964769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antifibrinolytic effects of carbon monoxide-releasing molecule-2 are fibrin and alpha2-antiplasmin dependent.
    Nielsen VG
    Blood Coagul Fibrinolysis; 2010 Sep; 21(6):584-7. PubMed ID: 20683324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbon monoxide releasing molecule-2 improves protamine-mediated hypocoagulation/hyperfibrinolysis in human plasma in vitro.
    Nielsen VG; Malayaman SN; Cohen JB; Persaud JM
    J Surg Res; 2012 Apr; 173(2):232-9. PubMed ID: 20950825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects of CORM-2, CORM-3 and CORM-A1 on coagulation in human plasma.
    Nielsen VG; Garza JI
    Blood Coagul Fibrinolysis; 2014 Dec; 25(8):801-5. PubMed ID: 25058038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbon monoxide releasing molecule-2 increases the velocity of thrombus growth and strength in human plasma.
    Nielsen VG; Kirklin JK; George JF
    Blood Coagul Fibrinolysis; 2009 Jul; 20(5):377-80. PubMed ID: 19417630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbon monoxide releasing molecule-2 enhances coagulation and diminishes fibrinolytic vulnerability in plasma exposed to heparin or argatroban.
    Nielsen VG; Khan ES; Kirklin JK; George JF
    Anesth Analg; 2010 Dec; 111(6):1347-52. PubMed ID: 21048101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinogen is a heme-associated, carbon monoxide sensing molecule: a preliminary report.
    Nielsen VG; Cohen JB; Malayaman SN; Nowak M; Vosseller K
    Blood Coagul Fibrinolysis; 2011 Jul; 22(5):443-7. PubMed ID: 21451399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodialysis patients have plasmatic hypercoagulability and decreased fibrinolytic vulnerability: role of carbon monoxide.
    Matika RW; Nielsen VG; Steinbrenner EB; Sussman AN; Madhrira M
    ASAIO J; 2014; 60(6):716-21. PubMed ID: 25232771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential heme-mediated modulation of Deinagkistrodon, Dispholidus, Protobothrops and Pseudonaja hemotoxic venom activity in human plasma.
    Nielsen VG; Frank N
    Biometals; 2018 Dec; 31(6):951-959. PubMed ID: 30132273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbon monoxide inhibits hemotoxic activity of Elapidae venoms: potential role of heme.
    Nielsen VG; Frank N; Matika RW
    Biometals; 2018 Feb; 31(1):51-59. PubMed ID: 29170850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombotic properties of water-soluble carbon monoxide-releasing molecules.
    Kramkowski K; Leszczynska A; Mogielnicki A; Chlopicki S; Fedorowicz A; Grochal E; Mann B; Brzoska T; Urano T; Motterlini R; Buczko W
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2149-57. PubMed ID: 22772756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.